Dr Damo Xu

  • Affiliate Researcher (Institute of Infection Immunity & Inflammation)

email: Damo.Xu@glasgow.ac.uk

RB226 Level 2, Iii - Gbrc, University Place, Glasgow G12 8TA

Publications

List by: Type | Date

Jump to: 2021 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1995 | 1994 | 1993
Number of items: 97.

2021

Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D. and Zhou, Y. (2021) The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduction and Targeted Therapy, 6(1), 255. (doi: 10.1038/s41392-021-00679-0) (PMID:34234112) (PMCID:PMC8261820)

2016

Komai-Koma, M., Wang, E., Kurowska-Stolarska, M. , Li, D., McSharry, C. and Xu, D. (2016) Interleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12. Immunobiology, 221(3), pp. 412-417. (doi: 10.1016/j.imbio.2015.11.013) (PMID:26688508) (PMCID:PMC4731778)

Zarpelon, A. C. et al. (2016) Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB Journal, 30(1), pp. 54-65. (doi: 10.1096/fj.14-267146) (PMID:26310268)

2015

Shi, X. et al. (2015) IL28B is associated with outcomes of chronic HBV infection. Yonsei Medical Journal, 56(3), pp. 625-633. (doi: 10.3349/ymj.2015.56.3.625) (PMID:25837166) (PMCID:PMC4397430)

2014

Li, D. et al. (2014) IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. Journal of Allergy and Clinical Immunology, 134(6), 1422-1432.e11. (doi: 10.1016/j.jaci.2014.05.011) (PMID:24985397) (PMCID:PMC4258609)

Komai-Koma, M., Li, D., Wang, E., Vaughan, D. and Xu, D. (2014) Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice. Immunology, 143(3), pp. 354-362. (doi: 10.1111/imm.12312)

Li, Y., Gao, Q., Yuan, X., Zhou, M., Peng, X., Liu, X., Zheng, X., Xu, D. and Li, M. (2014) Adenovirus expressing IFN-λ1 (IL-29) attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma. International Immunopharmacology, 21(1), pp. 156-162. (doi: 10.1016/j.intimp.2014.04.022)

Qiu, C., Li, Y., Zhou, M., Liu, J., Li, M., Wu, Y., Xu, D. and Li, M. (2014) Hydrodynamic delivery of IL-28B (IFN-λ3) gene ameliorates lung inflammation induced by cigarette smoke exposure in mice. Biochemical and Biophysical Research Communications, 447(3), pp. 513-519. (doi: 10.1016/j.bbrc.2014.04.010)

Sattler, S. et al. (2014) IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut. Journal of Autoimmunity, 50, pp. 107-122. (doi: 10.1016/j.jaut.2014.01.032) (PMID:24491821) (PMCID:PMC4012142)

2013

Pushparaj, P.N., Li, D., Komai-Koma, M., Guabiraba Brito, R., Alexander, J., McSharry, C. and Xu, D. (2013) Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. Immunology, 140(1), pp. 70-77. (doi: 10.1111/imm.12111)

Han, P., Zhao, J., Liu, S.-B., Yang, C.-J., Wang, Y.-Q., Wu, G.-C., Xu, D.-M. and Mi, W.-L. (2013) Interleukin-33 mediates formalin-induced inflammatory pain in mice. Neuroscience, 241, pp. 59-66. (doi: 10.1016/j.neuroscience.2013.03.019)

Zarpelon, A.C., Cunha, T.M., Alves-Filho, J.C., Pinto, L.G., Ferreira, S.H., McInnes, I.B. , Xu, D., Liew, F.Y., Cunha, F.Q. and Verri, W.A. (2013) IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2. British Journal of Pharmacology, 169(1), pp. 90-101. (doi: 10.1111/bph.12110) (PMID:23347081) (PMCID:PMC3632241)

Sattler, S., Smits, H.H., Xu, D. and Huang, F.-P. (2013) The evolutionary role of the IL-33/ST2 system in host immune defence. Archivum Immunologiae et Therapiae Experimentalis, 61(2), pp. 107-117. (doi: 10.1007/s00005-012-0208-8)

Qiu, C., Li, Y., Li, M., Li, M., Liu, X., McSharry, C. and Xu, D. (2013) Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice. Immunology, 138(1), pp. 76-82. (doi: 10.1111/imm.12020)

Sun, H., Lv, J., Tu, Z., Hu, X., Yan, H., Pan, Y., Xu, D., Lian, Z., Chi, X. and Niu, J. (2013) Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients. Experimental Biology and Medicine, 238(11), pp. 1275-1283. (doi: 10.1177/1535370213502626)

2012

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N. , Baker, A. H., McInnes, I. B. and Liew, F. Y. (2012) IL-33 reduces the development of atherosclerosis (vol 205, pg 339, 2008). Journal of Experimental Medicine, 209(13), p. 2515. (doi: 10.1084/jem.2007186820913c)

Komai-Koma, M. et al. (2012) Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy, 67(9), pp. 1118-1126. (doi: 10.1111/j.1398-9995.2012.02859.x) (PMID:22702477) (PMCID:PMC3660789)

Jiang, H.-R. et al. (2012) IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. European Journal of Immunology, 42(7), pp. 1804-1814. (doi: 10.1002/eji.201141947)

Lv, J. et al. (2012) Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic Hepatitis B virus infected patients. Mediators of Inflammation, 2012(804043), pp. 1-9. (doi: 10.1155/2012/804043)

Shi, X. et al. (2012) IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS ONE, 7(5), e37054. (doi: 10.1371/journal.pone.0037054) (PMID:22649509) (PMCID:PMC3359351)

Xuzhu, G., Komai-Koma, M., Leung, B.P., Howe, H.S., McSharry, C., McInnes, I.B. and Xu, D. (2012) Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Annals of the Rheumatic Diseases, 71(1), pp. 129-135. (doi: 10.1136/ard.2011.149831) (PMID:21953348)

2011

Komai-Koma, M., Gilchrist, D. S., McKenzie, A. N. J., Goodyear, C. S. , Xu, D. and Liew, F. Y. (2011) IL-33 activates B1 cells and exacerbates contact sensitivity. Journal of Immunology, 186(4), pp. 2584-2591. (doi: 10.4049/jimmunol.1002103)

Zhang, Y., Luo, F., Cai, Y., Liu, N., Wang, L., Xu, D. and Chu, Y. (2011) TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells. Journal of Immunology, 186(4), pp. 1963-1969. (doi: 10.4049/jimmunol.1002320) (PMID:21217015)

Jiang, Y., Li, W., Yu, L., Liu, J., Xin, G., Yan, H., Sun, P., Zhang, H., Xu, D. and Niu, J. (2011) Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cellular and Molecular Immunology, 8(1), pp. 75-82. (doi: 10.1038/cmi.2010.37)

2010

Stolarski, B., Kurowska-Stolarska, M. , Kewin, P., Xu, D. and Liew, F. Y. (2010) IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation. Journal of Immunology, 185(6), pp. 3472-3480. (doi: 10.4049/jimmunol.1000730)

Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M. , McKenzie, A. N., Xu, D., Sattar, N. , McInnes, I. B. and Liew, F. Y. (2010) Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research, 107(5), pp. 650-658. (doi: 10.1161/CIRCRESAHA.110.218867) (PMID:20634488) (PMCID:PMC4254700)

Verri, W. A. et al. (2010) IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Annals of the Rheumatic Diseases, 69(9), pp. 1697-1703. (doi: 10.1136/ard.2009.122655) (PMID:20472598)

Xu, D. et al. (2010) IL-33 exacerbates autoantibody-induced arthritis. Journal of Immunology, 184(5), pp. 2620-2626. (doi: 10.4049/jimmunol.0902685) (PMID:20139274)

Alves Filho, J. C. et al. (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nature Medicine, 16(6), pp. 708-712. (doi: 10.1038/nm.2156)

Murphy, G.E.J., Xu, D., Liew, F.Y. and McInnes, I.B. (2010) Role of interleukin 33 in human immunopathology. Annals of the Rheumatic Diseases, 69(Suppl), pp. 43-47. (doi: 10.1136/ard.2009.120113) (PMID:19995743)

2009

Kurowska-Stolarska, M. et al. (2009) IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation. Journal of Immunology, 183(10), pp. 6469-6477. (doi: 10.4049/jimmunol.0901575) (PMID:19841166)

Pushparaj, P. N., Tay, H. K., H'Ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y. and Melendez, A. J. (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proceedings of the National Academy of Sciences of the United States of America, 106(24), pp. 9773-9778. (doi: 10.1073/pnas.0901206106)

Komai-Koma, M., Gilchrist, D. S. and Xu, D. (2009) Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex. European Journal of Immunology, 39(6), pp. 1564-1572. (doi: 10.1002/eji.200838866)

McKimmie, C. S. et al. (2009) A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood, 113(18), pp. 4224-4231. (doi: 10.1182/blood-2008-08-174698) (PMID:19202130)

Trieu, A., Bokil, N., Dunn, J. A., Roberts, T. L., Xu, D., Liew, F. Y., Hume, D. A., Stacey, K. J. and Sweet, M. J. (2009) TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium. Immunology and Cell Biology, 87(3), pp. 218-225. (doi: 10.1038/icb.2008.95)

Jiang, H., Al Rasebi, Z., Mensah-Brown, E., Shahin, A., Xu, D., Goodyear, C. , Fukada, S., Liu, F., Liew, F. and Lukic, M. (2009) Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 182(2), pp. 1167-1173.

Murphy, G.E.J., Pitman, N.I., Kurowska-Stolarska, M. , Kewin, P., Xu, D., McSharry, C., Thomson, N.C. and Shepherd, M.C. (2009) Murine airway eosinophilia following IL-33 administration is eotaxin dependent. In: American Thoracic Society 2009 International Conference, San Diego, CA, USA, 15-20 May 2009, A4253. (doi: 10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A4253)

2008

Kurowska-Stolarska, M. et al. (2008) IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. Journal of Immunology, 181(7), pp. 4780-4790.

Kurowska-Stolarska, M. S. , Kewin, P., Stolarski, B., Fraser, A., Xu, D., McInnes, I. and Liew, F. Y. (2008) A role of IL-33 in bone turnover. In: 72nd Annual Scientific Meeting of the American College of Rheumatology and the 43rd Annual Scientific Meeting of the Association of Rheumatology Health Professionals, San Francisco CA, USA, 24-29 Oct 2008, S895.

Li, Y., Komai-Koma, M., Gilchrist, D.S., Hsu, D.K., Liu, F.-T., Spingall, T. and Xu, D. (2008) Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. Journal of Immunology, 181(4), pp. 2781-2789.

Xu, D. et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America, 105(31), pp. 10913-10918. (doi: 10.1073/pnas.0801898105) (PMID:18667700) (PMCID:PMC2491487)

Kewin, P., Kurowska-Stolarska, M. , Murphy, G., Pitman, N., ChooKang, B., Patel, M., Xu, D., Liew, F.Y. and Thomson, N. (2008) IL-33 is sufficient to induce eosinophilic airway inflammation, and exacerbates established inflammation, through increased local Th2 cytokine and chemokine production. In: Scottish Thoracic Society Meeting, Stirling, UK, 26 Oct 2007, p. 50. (doi: 10.1258/rsmsmj.53.2.48)

Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y. and Grencis, R. K. (2008) IL-33, a potent inducer of adaptive immunity to intestinal nematodes. Journal of Immunology, 180(4), pp. 2443-2449.

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N. , Baker, A. H., McInnes, I. B. and Liew, F. Y. (2008) IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine, 205(2), pp. 339-346. (doi: 10.1084/jem.20071868) (PMID:18268038) (PMCID:PMC2271006)

Al Ramadi, B., Fernandez-Cabezudo, M., El Hasasna, H., Al Salam, S., Attoub, S., Xu, D. and Chouaib, S. (2008) Attenuated Bacteria as Effectors in Cancer Immunotherapy. Recent Advances in Clinical Oncology, 1138, pp. 351-357.

Verri, Jr., W. A., Guerrero, A. T. G., Fukada, S. Y., Valerio, D. A., Cunha, T. M., Xu, D., Ferreira, S. H., Liew, F. Y. and Cunha, F. Q. (2008) IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proceedings of the National Academy of Sciences of the United States of America, 105(7), pp. 2723-2728. (doi: 10.1073/pnas.0712116105)

2007

Komai-Koma, M., Li, Y., Liew, F. Y., McInnes, I. B. , McKenzie, A. N. J. and Xu, D. (2007) IL-33 is a chemoattractant for human Th2 cells. European Journal of Immunology, 37(10), pp. 2779-2786. (doi: 10.1002/eji.200737547) (PMID:17853410)

Amaral, F. A., Fagundes, C. T., Liew, F. Y., Souza, A. L. S., Souza, D. G., Teixeira, M. M., Vieira, A. T. and Xu, D. (2007) ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. Journal of Leukocyte Biology, 81, pp. 492-499. (doi: 10.1189/jlb.0606422)

Kewin, P., Kurowska-Stolarska, M. , Murphy, G., Pitman, N., ChooKang, B., Patel, M., Xu, D., Liew, F.Y. and Thomson, N. (2007) IL-33 is sufficient to induce eosinophilic airway inflammation, and exacerbates established inflammation, through increased ST2 dependent local Th2 cytokine and chemokine production. In: Winter Meeting of the British-Thoracic-Society, London, UK, 05-07 Dec 2007, A1.

2006

Liu, H., Komai-Koma, M., Xu, D. and Liew, F. (2006) Toll-like receptor 2 signaling modulates the functions of CD4(+)CD25(+) regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 7048-7053. (doi: 10.1073/pnas.0601554103)

2005

Brint, E., Liew, F., O'Neill, L. and Xu, D. (2005) Negative regulation of Toll-like receptor-mediated immune responses. Nature Reviews Immunology, 5, pp. 446-458. (doi: 10.1038/nri1630)

Choo-Kang, B., Kewin, P., Liew, F., McSharry, C., Patel, M., Thomson, N. and Xu, D. (2005) Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. European Journal of Immunology, 35, pp. 3581-3590. (doi: 10.1002/eji.200535421)

Choo-Kang, B., Kewin, P., Liew, F., McSharry, C., Patel, M., Thomson, N. and Xu, D. (2005) TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. Journal of Immunology, 174, pp. 7558-7563.

Komai-Koma, M., Liew, F. and Xu, D. (2005) Expression and function of Toll-like receptor on T cells. Cellular Immunology, 233, pp. 85-89. (doi: 10.1016/j.cellimm.2005.04.019)

Liew, F., Liu, H. and Xu, D. (2005) A novel negative regulator for IL-1 receptor and Toll-like receptor 4. Immunology Letters, 96, pp. 27-31. (doi: 10.1016/j.imlet.2004.07.008)

Liew, F., Patel, M. and Xu, D. (2005) Toll-like receptor 2 signalling and inflammation. Annals of the Rheumatic Diseases, 64, pp. 104-105. (doi: 10.1136/ard.2005.042515)

2004

al Ramadi, B., Fernandez-Cabezudo, M., Mustafa, N. and Xu, D. (2004) Activation of innate immune responses by IL-2-expressing Salmonella lyphimurium is independent of Toll-like receptor 4. Molecular Immunology, 40, pp. 671-679. (doi: 10.1016/j.molimm.2003.09.005)

Brint, E., Dunne, A., Liew, F., Liu, H., McKenzie, A., O'Neill, L. and Xu, D. (2004) ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nature Immunology, 5, pp. 373-379. (doi: 10.1038/ni1050)

Demonacos, C., Jansson, M., Krstic-Demonacos, M., La Thangue, N.B., O'Connor, D.P., Smith, L. and Xu, D.M. (2004) A new effector pathway links ATM kinase with the DNA damage response. Nature Cell Biology, 6(10), 968-+. (doi: 10.1038/ncb1170)

Komai-Koma, M., Jones, L., Ogg, G., Xu, D. and Liew, F. (2004) TLR2 is expressed on activated T cells as a costimulatory receptor. Proceedings of the National Academy of Sciences of the United States of America, 101, pp. 3029-3034. (doi: 10.1073/pnas.0400171101)

Komai-Koma, M., Liew, F. and Xu, D. (2004) A toll for T cell costimulation. Annals of the Rheumatic Diseases, 63, pp. 76-78. (doi: 10.1136/ard.2004.028308)

Sweet, M., Trajkovic, V. and Xu, D. (2004) T1/ST2 - an IL-1 receptor-like modulator of immune responses. Cytokine and Growth Factor Reviews, 15, pp. 87-95. (doi: 10.1016/j.cytogfr.2004.02.004)

Wei, X., Niedbala, W., Xu, D., Luo, Z., Pollock, K. and Brewer, J. (2004) Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunology Letters, 94, pp. 35-37. (doi: 10.1016/j.imlet.2004.04.001)

2003

Alexander, J., Campbell, C., Komai-Koma, M., Liew, F., Liu, H., McSharry, C. and Xu, D. (2003) CD4(+)CD25(+) regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. Journal of Immunology, 170, pp. 394-399.

Eaton, A., Xu, D. and Garside, P. (2003) Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology, 108, pp. 196-203.

Gracie, J., Komai-Koma, M., Liew, F., McInnes, I. , Thomson, N., Wei, X. and Xu, D. (2003) Chemoattraction of human T cells by IL-18. Journal of Immunology, 170, pp. 1084-1090. (doi: 10.4049/jimmunol.170.2.1084) (PMID:12517977)

Hu, B., Liew, F., Liu, H. and Xu, D. (2003) CD4+CD25+ regulatory T cells cure murine colitis: The role of IL-10, TGF-beta, and CTLA4. Journal of Immunology, 171, pp. 5012-5017.

2002

Campbell, C., Hume, D., Liew, F., McDonald, R., Sester, D., Stacey, K., Sweet, M. and Xu, D. (2002) Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. Journal of Immunology, 168, pp. 392-399.

2001

Abouhaidar, M., Al Dhaheri, M., al Ramadi, B., Fernandez-Cabezudo, M., Liew, F., Lukic, M., Mustafa, N. and Xu, D. (2001) Influence of vector-encoded cytokines on anti-Salmonella immunity: Divergent effects of interleukin-2 and tumor necrosis factor alpha. Infection and Immunity, 69, pp. 3980-3988.

Bach, F., Csizmadia, E., Lee, J., Liew, F., Lin, Y., Smith, N., Soares, M., Wang, N. and Xu, D. (2001) TH2 cytokines regulate gene expression and proinflammatory responses in xenografts. Transplantation Proceedings, 33, pp. 776-777.

Campbell, C., Kang, D., Leung, B., Liew, F., Schulz, K., Sogaard, M., Sweet, M., Trajkovic, V. and Xu, D. (2001) A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of toll-like receptor 4 expression. Journal of Immunology, 166, pp. 6633-6639.

Carter, R., Chan, W., Klemenz, R., Liew, F., Sweet, M. and Xu, D. (2001) Regulation of ST2L expression on T helper (Th) type 2 cells. European Journal of Immunology, 31, pp. 2979-2985.

2000

Smith, K., Pottage, L., Thomas, E., Leishman, A., Doig, T., Xu, D., Liew, F. and Garside, P. (2000) Th1 and Th2CD4(+) T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. Journal of Immunology, 165(6), pp. 3136-3144.

Xu, D., Trajkovic, V., Hunter, D., Leung, B. P., Schulz, K., Gracie, J. A., McInnes, I. B. and Liew, F. Y. (2000) IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. European Journal of Immunology, 30(11), pp. 3147-3156. (doi: 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J) (PMID:11093129)

1999

Gracie, J. A. et al. (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. Journal of Clinical Investigation, 104(10), pp. 1393-1401. (doi: 10.1172/JCI7317) (PMID:10562301) (PMCID:PMC409841)

Kropf, P., Schopf, L. R., Chung, C. L., Xu, D., Liew, F. Y., Sypek, J. P. and Müller, I. (1999) Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. European Journal of Immunology, 29(11), pp. 3621-3628. (doi: 10.1002/(SICI)1521-4141(199911)29:11<3621::AID-IMMU3621>3.0.CO;2-Z) (PMID:10556817)

Niedbala, W., Wei, X.-Q., Piedrafita, D., Xu, D. and Liew, F. Y. (1999) Effects of nitric oxide on the induction and differentiation of Th1 cells. European Journal of Immunology, 29(8), pp. 2498-2505. (doi: 10.1002/(SICI)1521-4141(199908)29:08<2498::AID-IMMU2498>3.0.CO;2-M) (PMID:10458764)

Liew, F.Y., Xu, D. and Ling Chan, W. (1999) Immune effector mechanism in parasitic infections. Immunology Letters, 65(1-2), pp. 101-104. (doi: 10.1016/S0165-2478(98)00131-X) (PMID:10065634)

Piedrafita, D. et al. (1999) Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. European Journal of Immunology, 29(1), pp. 235-244. (doi: 10.1002/(SICI)1521-4141(199901)29:01<235::AID-IMMU235>3.0.CO;2-S) (PMID:9933105)

Huggins, M.L., Huang, F.P., Xu, D., Lindop, G. and Stott, D.I. (1999) Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-b1 gene therapy using attenuated Salmonella typhimurium as gene carrier. Lupus, 8, pp. 29-38. (doi: 10.1191/096120399678847308)

Piedrafita, D., Xu, D., Hunter, D., Harrison, R. A. and Liew, F. Y. (1999) Protective immune responses induced by vaccination with an expression genomic library of leishmania major. Journal of Immunology, 163(3), pp. 1467-1472. (PMID:10415048)

1998

Huang, F.-P., Niedbala, W., Wei, X.-Q., Xu, D., Feng, G.-j., Robinson, J. H., Lam, C. and Liew, F. Y. (1998) Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European Journal of Immunology, 28(12), pp. 4062-4070. (doi: 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K) (PMID:9862342)

Xu, D., Chan, W. L., Leung, B. P., Hunter, D., Schulz, K., Carter, R. W., McInnes, I. B. , Robinson, J. H. and Liew, F. Y. (1998) Selective expression and functions of Interleukin 18 receptor on T Helper (Th) type 1 but not Th2 cells. Journal of Experimental Medicine, 188(8), pp. 1485-1492. (doi: 10.1084/jem.188.8.1485) (PMID:9782125) (PMCID:PMC2213413)

Huang, F.-P., Xu, D., Esfandiari, E.-O., Sands, W., Wei, X.-q. and Liew, F. Y. (1998) Cutting edge: Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated interleukin-12 synthesis, strong Th1 responses and enhanced nitric oxide production. Journal of Immunology, 160(9), pp. 4143-4147. (PMID:9574511)

Xu, D., McSorley, S. J., Tetley, L., Chatfield, S., Dougan, G., Chan, W. L., Satoskar, A., David, J. R. and Liew, F. Y. (1998) Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. Journal of Immunology, 160(3), pp. 1285-1289. (PMID:9570545)

1997

Huggins, M.L., Huang, F.P., Xu, D., Lindop, G. and Stott, D.I. (1997) Modulation of the autoimmune response in lupus mice by oral administration of attenuated Salmonella typhimurium expressing the IL-2 and TGF-b genes. Annals of the New York Academy of Sciences, 815, pp. 499-502. (doi: 10.1111/j.1749-6632.1997.tb52114.x)

Mcsorley, S. J., Xu, D. and Liew, F.Y. (1997) Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infection and Immunity, 65(1), pp. 171-178. (PMID:8975908)

1995

Wei, X.-q., Charles, I. G., Smith, A., Ure, J., Feng, G.-j., Huang, F.-p., Xu, D., Mullers, W., Moncada, S. and Liew, F. Y. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature, 375(6530), pp. 408-411. (doi: 10.1038/375408a0) (PMID:7539113)

Xu, D. and Liew, F.Y. (1995) Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology, 84(2), pp. 173-176. (PMID:7750991)

Ianaro, A., Xu, D., O'Donnell, C.A. , Di Rosa, M. and Liew, F.Y. (1995) Expression of TGF-beta in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology, 84(1), pp. 8-15. (PMID:7890306)

Xu, D., McSorley, S.J., Chatfield, S.N., Dougan, G. and Liew, F.Y. (1995) Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-). Immunology, 85(1), pp. 1-7. (PMID:7635511)

1994

Xu, D. and Liew, F.Y. (1994) Genetic vaccination against leishmaniasis. Vaccine, 12(16), pp. 1534-1536. (doi: 10.1016/0264-410X(94)90079-5) (PMID:7879420)

Taylor-Robinson, A. W., Liew, F. Y., Severn, A., Xu, D., McSorley, S. J., Garside, P. , Padron, J. and Phillips, R. S. (1994) Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. European Journal of Immunology, 24(4), pp. 980-984. (doi: 10.1002/eji.1830240430) (PMID:8149966)

Ianaro, A., O'Donnell, C.A. and Xu, D. (1994) The role of nitric oxide in Carrageenin-induced inflammation. In: Moncada, S. (ed.) Biology of Nitric Oxide. Portland Press: London.

Sands, W. A., Bulut, V., Severn, A., Xu, D. and Liew, F. Y. (1994) Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. European Journal of Immunology, 24(10), pp. 2345-2350. (doi: 10.1002/eji.1830241013) (PMID:7523136)

1993

Severn, A., Xu, D., Doyle, J., Leal, L. M. C., O'Donnell, C. A. , Brett, S. J., Moss, D. W. and Liew, F. Y. (1993) Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity. European Journal of Immunology, 23(7), pp. 1711-1714. (doi: 10.1002/eji.1830230747) (PMID:7686861)

Cunha, F. Q., Assreuy, J., Xu, D., Charles, I., Liew, F. Y. and Moncada, S. (1993) Repeated induction of nitric oxide synthase and leishmanicidal activity in murine macrophages. European Journal of Immunology, 23(6), pp. 1385-1388. (doi: 10.1002/eji.1830230631) (PMID:7684689)

This list was generated on Thu Dec 9 09:20:11 2021 GMT.
Number of items: 97.

Articles

Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D. and Zhou, Y. (2021) The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduction and Targeted Therapy, 6(1), 255. (doi: 10.1038/s41392-021-00679-0) (PMID:34234112) (PMCID:PMC8261820)

Komai-Koma, M., Wang, E., Kurowska-Stolarska, M. , Li, D., McSharry, C. and Xu, D. (2016) Interleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12. Immunobiology, 221(3), pp. 412-417. (doi: 10.1016/j.imbio.2015.11.013) (PMID:26688508) (PMCID:PMC4731778)

Zarpelon, A. C. et al. (2016) Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain. FASEB Journal, 30(1), pp. 54-65. (doi: 10.1096/fj.14-267146) (PMID:26310268)

Shi, X. et al. (2015) IL28B is associated with outcomes of chronic HBV infection. Yonsei Medical Journal, 56(3), pp. 625-633. (doi: 10.3349/ymj.2015.56.3.625) (PMID:25837166) (PMCID:PMC4397430)

Li, D. et al. (2014) IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. Journal of Allergy and Clinical Immunology, 134(6), 1422-1432.e11. (doi: 10.1016/j.jaci.2014.05.011) (PMID:24985397) (PMCID:PMC4258609)

Komai-Koma, M., Li, D., Wang, E., Vaughan, D. and Xu, D. (2014) Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice. Immunology, 143(3), pp. 354-362. (doi: 10.1111/imm.12312)

Li, Y., Gao, Q., Yuan, X., Zhou, M., Peng, X., Liu, X., Zheng, X., Xu, D. and Li, M. (2014) Adenovirus expressing IFN-λ1 (IL-29) attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma. International Immunopharmacology, 21(1), pp. 156-162. (doi: 10.1016/j.intimp.2014.04.022)

Qiu, C., Li, Y., Zhou, M., Liu, J., Li, M., Wu, Y., Xu, D. and Li, M. (2014) Hydrodynamic delivery of IL-28B (IFN-λ3) gene ameliorates lung inflammation induced by cigarette smoke exposure in mice. Biochemical and Biophysical Research Communications, 447(3), pp. 513-519. (doi: 10.1016/j.bbrc.2014.04.010)

Sattler, S. et al. (2014) IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut. Journal of Autoimmunity, 50, pp. 107-122. (doi: 10.1016/j.jaut.2014.01.032) (PMID:24491821) (PMCID:PMC4012142)

Pushparaj, P.N., Li, D., Komai-Koma, M., Guabiraba Brito, R., Alexander, J., McSharry, C. and Xu, D. (2013) Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. Immunology, 140(1), pp. 70-77. (doi: 10.1111/imm.12111)

Han, P., Zhao, J., Liu, S.-B., Yang, C.-J., Wang, Y.-Q., Wu, G.-C., Xu, D.-M. and Mi, W.-L. (2013) Interleukin-33 mediates formalin-induced inflammatory pain in mice. Neuroscience, 241, pp. 59-66. (doi: 10.1016/j.neuroscience.2013.03.019)

Zarpelon, A.C., Cunha, T.M., Alves-Filho, J.C., Pinto, L.G., Ferreira, S.H., McInnes, I.B. , Xu, D., Liew, F.Y., Cunha, F.Q. and Verri, W.A. (2013) IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2. British Journal of Pharmacology, 169(1), pp. 90-101. (doi: 10.1111/bph.12110) (PMID:23347081) (PMCID:PMC3632241)

Sattler, S., Smits, H.H., Xu, D. and Huang, F.-P. (2013) The evolutionary role of the IL-33/ST2 system in host immune defence. Archivum Immunologiae et Therapiae Experimentalis, 61(2), pp. 107-117. (doi: 10.1007/s00005-012-0208-8)

Qiu, C., Li, Y., Li, M., Li, M., Liu, X., McSharry, C. and Xu, D. (2013) Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice. Immunology, 138(1), pp. 76-82. (doi: 10.1111/imm.12020)

Sun, H., Lv, J., Tu, Z., Hu, X., Yan, H., Pan, Y., Xu, D., Lian, Z., Chi, X. and Niu, J. (2013) Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients. Experimental Biology and Medicine, 238(11), pp. 1275-1283. (doi: 10.1177/1535370213502626)

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N. , Baker, A. H., McInnes, I. B. and Liew, F. Y. (2012) IL-33 reduces the development of atherosclerosis (vol 205, pg 339, 2008). Journal of Experimental Medicine, 209(13), p. 2515. (doi: 10.1084/jem.2007186820913c)

Komai-Koma, M. et al. (2012) Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy, 67(9), pp. 1118-1126. (doi: 10.1111/j.1398-9995.2012.02859.x) (PMID:22702477) (PMCID:PMC3660789)

Jiang, H.-R. et al. (2012) IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. European Journal of Immunology, 42(7), pp. 1804-1814. (doi: 10.1002/eji.201141947)

Lv, J. et al. (2012) Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic Hepatitis B virus infected patients. Mediators of Inflammation, 2012(804043), pp. 1-9. (doi: 10.1155/2012/804043)

Shi, X. et al. (2012) IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS ONE, 7(5), e37054. (doi: 10.1371/journal.pone.0037054) (PMID:22649509) (PMCID:PMC3359351)

Xuzhu, G., Komai-Koma, M., Leung, B.P., Howe, H.S., McSharry, C., McInnes, I.B. and Xu, D. (2012) Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Annals of the Rheumatic Diseases, 71(1), pp. 129-135. (doi: 10.1136/ard.2011.149831) (PMID:21953348)

Komai-Koma, M., Gilchrist, D. S., McKenzie, A. N. J., Goodyear, C. S. , Xu, D. and Liew, F. Y. (2011) IL-33 activates B1 cells and exacerbates contact sensitivity. Journal of Immunology, 186(4), pp. 2584-2591. (doi: 10.4049/jimmunol.1002103)

Zhang, Y., Luo, F., Cai, Y., Liu, N., Wang, L., Xu, D. and Chu, Y. (2011) TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells. Journal of Immunology, 186(4), pp. 1963-1969. (doi: 10.4049/jimmunol.1002320) (PMID:21217015)

Jiang, Y., Li, W., Yu, L., Liu, J., Xin, G., Yan, H., Sun, P., Zhang, H., Xu, D. and Niu, J. (2011) Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cellular and Molecular Immunology, 8(1), pp. 75-82. (doi: 10.1038/cmi.2010.37)

Stolarski, B., Kurowska-Stolarska, M. , Kewin, P., Xu, D. and Liew, F. Y. (2010) IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation. Journal of Immunology, 185(6), pp. 3472-3480. (doi: 10.4049/jimmunol.1000730)

Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M. , McKenzie, A. N., Xu, D., Sattar, N. , McInnes, I. B. and Liew, F. Y. (2010) Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research, 107(5), pp. 650-658. (doi: 10.1161/CIRCRESAHA.110.218867) (PMID:20634488) (PMCID:PMC4254700)

Verri, W. A. et al. (2010) IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Annals of the Rheumatic Diseases, 69(9), pp. 1697-1703. (doi: 10.1136/ard.2009.122655) (PMID:20472598)

Xu, D. et al. (2010) IL-33 exacerbates autoantibody-induced arthritis. Journal of Immunology, 184(5), pp. 2620-2626. (doi: 10.4049/jimmunol.0902685) (PMID:20139274)

Alves Filho, J. C. et al. (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nature Medicine, 16(6), pp. 708-712. (doi: 10.1038/nm.2156)

Murphy, G.E.J., Xu, D., Liew, F.Y. and McInnes, I.B. (2010) Role of interleukin 33 in human immunopathology. Annals of the Rheumatic Diseases, 69(Suppl), pp. 43-47. (doi: 10.1136/ard.2009.120113) (PMID:19995743)

Kurowska-Stolarska, M. et al. (2009) IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation. Journal of Immunology, 183(10), pp. 6469-6477. (doi: 10.4049/jimmunol.0901575) (PMID:19841166)

Pushparaj, P. N., Tay, H. K., H'Ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y. and Melendez, A. J. (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proceedings of the National Academy of Sciences of the United States of America, 106(24), pp. 9773-9778. (doi: 10.1073/pnas.0901206106)

Komai-Koma, M., Gilchrist, D. S. and Xu, D. (2009) Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex. European Journal of Immunology, 39(6), pp. 1564-1572. (doi: 10.1002/eji.200838866)

McKimmie, C. S. et al. (2009) A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood, 113(18), pp. 4224-4231. (doi: 10.1182/blood-2008-08-174698) (PMID:19202130)

Trieu, A., Bokil, N., Dunn, J. A., Roberts, T. L., Xu, D., Liew, F. Y., Hume, D. A., Stacey, K. J. and Sweet, M. J. (2009) TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium. Immunology and Cell Biology, 87(3), pp. 218-225. (doi: 10.1038/icb.2008.95)

Jiang, H., Al Rasebi, Z., Mensah-Brown, E., Shahin, A., Xu, D., Goodyear, C. , Fukada, S., Liu, F., Liew, F. and Lukic, M. (2009) Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 182(2), pp. 1167-1173.

Kurowska-Stolarska, M. et al. (2008) IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. Journal of Immunology, 181(7), pp. 4780-4790.

Li, Y., Komai-Koma, M., Gilchrist, D.S., Hsu, D.K., Liu, F.-T., Spingall, T. and Xu, D. (2008) Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. Journal of Immunology, 181(4), pp. 2781-2789.

Xu, D. et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America, 105(31), pp. 10913-10918. (doi: 10.1073/pnas.0801898105) (PMID:18667700) (PMCID:PMC2491487)

Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y. and Grencis, R. K. (2008) IL-33, a potent inducer of adaptive immunity to intestinal nematodes. Journal of Immunology, 180(4), pp. 2443-2449.

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N. , Baker, A. H., McInnes, I. B. and Liew, F. Y. (2008) IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine, 205(2), pp. 339-346. (doi: 10.1084/jem.20071868) (PMID:18268038) (PMCID:PMC2271006)

Al Ramadi, B., Fernandez-Cabezudo, M., El Hasasna, H., Al Salam, S., Attoub, S., Xu, D. and Chouaib, S. (2008) Attenuated Bacteria as Effectors in Cancer Immunotherapy. Recent Advances in Clinical Oncology, 1138, pp. 351-357.

Verri, Jr., W. A., Guerrero, A. T. G., Fukada, S. Y., Valerio, D. A., Cunha, T. M., Xu, D., Ferreira, S. H., Liew, F. Y. and Cunha, F. Q. (2008) IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proceedings of the National Academy of Sciences of the United States of America, 105(7), pp. 2723-2728. (doi: 10.1073/pnas.0712116105)

Komai-Koma, M., Li, Y., Liew, F. Y., McInnes, I. B. , McKenzie, A. N. J. and Xu, D. (2007) IL-33 is a chemoattractant for human Th2 cells. European Journal of Immunology, 37(10), pp. 2779-2786. (doi: 10.1002/eji.200737547) (PMID:17853410)

Amaral, F. A., Fagundes, C. T., Liew, F. Y., Souza, A. L. S., Souza, D. G., Teixeira, M. M., Vieira, A. T. and Xu, D. (2007) ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. Journal of Leukocyte Biology, 81, pp. 492-499. (doi: 10.1189/jlb.0606422)

Liu, H., Komai-Koma, M., Xu, D. and Liew, F. (2006) Toll-like receptor 2 signaling modulates the functions of CD4(+)CD25(+) regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 7048-7053. (doi: 10.1073/pnas.0601554103)

Brint, E., Liew, F., O'Neill, L. and Xu, D. (2005) Negative regulation of Toll-like receptor-mediated immune responses. Nature Reviews Immunology, 5, pp. 446-458. (doi: 10.1038/nri1630)

Choo-Kang, B., Kewin, P., Liew, F., McSharry, C., Patel, M., Thomson, N. and Xu, D. (2005) Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. European Journal of Immunology, 35, pp. 3581-3590. (doi: 10.1002/eji.200535421)

Choo-Kang, B., Kewin, P., Liew, F., McSharry, C., Patel, M., Thomson, N. and Xu, D. (2005) TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. Journal of Immunology, 174, pp. 7558-7563.

Komai-Koma, M., Liew, F. and Xu, D. (2005) Expression and function of Toll-like receptor on T cells. Cellular Immunology, 233, pp. 85-89. (doi: 10.1016/j.cellimm.2005.04.019)

Liew, F., Liu, H. and Xu, D. (2005) A novel negative regulator for IL-1 receptor and Toll-like receptor 4. Immunology Letters, 96, pp. 27-31. (doi: 10.1016/j.imlet.2004.07.008)

Liew, F., Patel, M. and Xu, D. (2005) Toll-like receptor 2 signalling and inflammation. Annals of the Rheumatic Diseases, 64, pp. 104-105. (doi: 10.1136/ard.2005.042515)

al Ramadi, B., Fernandez-Cabezudo, M., Mustafa, N. and Xu, D. (2004) Activation of innate immune responses by IL-2-expressing Salmonella lyphimurium is independent of Toll-like receptor 4. Molecular Immunology, 40, pp. 671-679. (doi: 10.1016/j.molimm.2003.09.005)

Brint, E., Dunne, A., Liew, F., Liu, H., McKenzie, A., O'Neill, L. and Xu, D. (2004) ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nature Immunology, 5, pp. 373-379. (doi: 10.1038/ni1050)

Demonacos, C., Jansson, M., Krstic-Demonacos, M., La Thangue, N.B., O'Connor, D.P., Smith, L. and Xu, D.M. (2004) A new effector pathway links ATM kinase with the DNA damage response. Nature Cell Biology, 6(10), 968-+. (doi: 10.1038/ncb1170)

Komai-Koma, M., Jones, L., Ogg, G., Xu, D. and Liew, F. (2004) TLR2 is expressed on activated T cells as a costimulatory receptor. Proceedings of the National Academy of Sciences of the United States of America, 101, pp. 3029-3034. (doi: 10.1073/pnas.0400171101)

Komai-Koma, M., Liew, F. and Xu, D. (2004) A toll for T cell costimulation. Annals of the Rheumatic Diseases, 63, pp. 76-78. (doi: 10.1136/ard.2004.028308)

Sweet, M., Trajkovic, V. and Xu, D. (2004) T1/ST2 - an IL-1 receptor-like modulator of immune responses. Cytokine and Growth Factor Reviews, 15, pp. 87-95. (doi: 10.1016/j.cytogfr.2004.02.004)

Wei, X., Niedbala, W., Xu, D., Luo, Z., Pollock, K. and Brewer, J. (2004) Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunology Letters, 94, pp. 35-37. (doi: 10.1016/j.imlet.2004.04.001)

Alexander, J., Campbell, C., Komai-Koma, M., Liew, F., Liu, H., McSharry, C. and Xu, D. (2003) CD4(+)CD25(+) regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. Journal of Immunology, 170, pp. 394-399.

Eaton, A., Xu, D. and Garside, P. (2003) Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology, 108, pp. 196-203.

Gracie, J., Komai-Koma, M., Liew, F., McInnes, I. , Thomson, N., Wei, X. and Xu, D. (2003) Chemoattraction of human T cells by IL-18. Journal of Immunology, 170, pp. 1084-1090. (doi: 10.4049/jimmunol.170.2.1084) (PMID:12517977)

Hu, B., Liew, F., Liu, H. and Xu, D. (2003) CD4+CD25+ regulatory T cells cure murine colitis: The role of IL-10, TGF-beta, and CTLA4. Journal of Immunology, 171, pp. 5012-5017.

Campbell, C., Hume, D., Liew, F., McDonald, R., Sester, D., Stacey, K., Sweet, M. and Xu, D. (2002) Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. Journal of Immunology, 168, pp. 392-399.

Abouhaidar, M., Al Dhaheri, M., al Ramadi, B., Fernandez-Cabezudo, M., Liew, F., Lukic, M., Mustafa, N. and Xu, D. (2001) Influence of vector-encoded cytokines on anti-Salmonella immunity: Divergent effects of interleukin-2 and tumor necrosis factor alpha. Infection and Immunity, 69, pp. 3980-3988.

Bach, F., Csizmadia, E., Lee, J., Liew, F., Lin, Y., Smith, N., Soares, M., Wang, N. and Xu, D. (2001) TH2 cytokines regulate gene expression and proinflammatory responses in xenografts. Transplantation Proceedings, 33, pp. 776-777.

Campbell, C., Kang, D., Leung, B., Liew, F., Schulz, K., Sogaard, M., Sweet, M., Trajkovic, V. and Xu, D. (2001) A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of toll-like receptor 4 expression. Journal of Immunology, 166, pp. 6633-6639.

Carter, R., Chan, W., Klemenz, R., Liew, F., Sweet, M. and Xu, D. (2001) Regulation of ST2L expression on T helper (Th) type 2 cells. European Journal of Immunology, 31, pp. 2979-2985.

Smith, K., Pottage, L., Thomas, E., Leishman, A., Doig, T., Xu, D., Liew, F. and Garside, P. (2000) Th1 and Th2CD4(+) T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. Journal of Immunology, 165(6), pp. 3136-3144.

Xu, D., Trajkovic, V., Hunter, D., Leung, B. P., Schulz, K., Gracie, J. A., McInnes, I. B. and Liew, F. Y. (2000) IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. European Journal of Immunology, 30(11), pp. 3147-3156. (doi: 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J) (PMID:11093129)

Gracie, J. A. et al. (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. Journal of Clinical Investigation, 104(10), pp. 1393-1401. (doi: 10.1172/JCI7317) (PMID:10562301) (PMCID:PMC409841)

Kropf, P., Schopf, L. R., Chung, C. L., Xu, D., Liew, F. Y., Sypek, J. P. and Müller, I. (1999) Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. European Journal of Immunology, 29(11), pp. 3621-3628. (doi: 10.1002/(SICI)1521-4141(199911)29:11<3621::AID-IMMU3621>3.0.CO;2-Z) (PMID:10556817)

Niedbala, W., Wei, X.-Q., Piedrafita, D., Xu, D. and Liew, F. Y. (1999) Effects of nitric oxide on the induction and differentiation of Th1 cells. European Journal of Immunology, 29(8), pp. 2498-2505. (doi: 10.1002/(SICI)1521-4141(199908)29:08<2498::AID-IMMU2498>3.0.CO;2-M) (PMID:10458764)

Liew, F.Y., Xu, D. and Ling Chan, W. (1999) Immune effector mechanism in parasitic infections. Immunology Letters, 65(1-2), pp. 101-104. (doi: 10.1016/S0165-2478(98)00131-X) (PMID:10065634)

Piedrafita, D. et al. (1999) Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. European Journal of Immunology, 29(1), pp. 235-244. (doi: 10.1002/(SICI)1521-4141(199901)29:01<235::AID-IMMU235>3.0.CO;2-S) (PMID:9933105)

Huggins, M.L., Huang, F.P., Xu, D., Lindop, G. and Stott, D.I. (1999) Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-b1 gene therapy using attenuated Salmonella typhimurium as gene carrier. Lupus, 8, pp. 29-38. (doi: 10.1191/096120399678847308)

Piedrafita, D., Xu, D., Hunter, D., Harrison, R. A. and Liew, F. Y. (1999) Protective immune responses induced by vaccination with an expression genomic library of leishmania major. Journal of Immunology, 163(3), pp. 1467-1472. (PMID:10415048)

Huang, F.-P., Niedbala, W., Wei, X.-Q., Xu, D., Feng, G.-j., Robinson, J. H., Lam, C. and Liew, F. Y. (1998) Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European Journal of Immunology, 28(12), pp. 4062-4070. (doi: 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K) (PMID:9862342)

Xu, D., Chan, W. L., Leung, B. P., Hunter, D., Schulz, K., Carter, R. W., McInnes, I. B. , Robinson, J. H. and Liew, F. Y. (1998) Selective expression and functions of Interleukin 18 receptor on T Helper (Th) type 1 but not Th2 cells. Journal of Experimental Medicine, 188(8), pp. 1485-1492. (doi: 10.1084/jem.188.8.1485) (PMID:9782125) (PMCID:PMC2213413)

Huang, F.-P., Xu, D., Esfandiari, E.-O., Sands, W., Wei, X.-q. and Liew, F. Y. (1998) Cutting edge: Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated interleukin-12 synthesis, strong Th1 responses and enhanced nitric oxide production. Journal of Immunology, 160(9), pp. 4143-4147. (PMID:9574511)

Xu, D., McSorley, S. J., Tetley, L., Chatfield, S., Dougan, G., Chan, W. L., Satoskar, A., David, J. R. and Liew, F. Y. (1998) Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. Journal of Immunology, 160(3), pp. 1285-1289. (PMID:9570545)

Huggins, M.L., Huang, F.P., Xu, D., Lindop, G. and Stott, D.I. (1997) Modulation of the autoimmune response in lupus mice by oral administration of attenuated Salmonella typhimurium expressing the IL-2 and TGF-b genes. Annals of the New York Academy of Sciences, 815, pp. 499-502. (doi: 10.1111/j.1749-6632.1997.tb52114.x)

Mcsorley, S. J., Xu, D. and Liew, F.Y. (1997) Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infection and Immunity, 65(1), pp. 171-178. (PMID:8975908)

Wei, X.-q., Charles, I. G., Smith, A., Ure, J., Feng, G.-j., Huang, F.-p., Xu, D., Mullers, W., Moncada, S. and Liew, F. Y. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature, 375(6530), pp. 408-411. (doi: 10.1038/375408a0) (PMID:7539113)

Xu, D. and Liew, F.Y. (1995) Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology, 84(2), pp. 173-176. (PMID:7750991)

Ianaro, A., Xu, D., O'Donnell, C.A. , Di Rosa, M. and Liew, F.Y. (1995) Expression of TGF-beta in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology, 84(1), pp. 8-15. (PMID:7890306)

Xu, D., McSorley, S.J., Chatfield, S.N., Dougan, G. and Liew, F.Y. (1995) Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-). Immunology, 85(1), pp. 1-7. (PMID:7635511)

Xu, D. and Liew, F.Y. (1994) Genetic vaccination against leishmaniasis. Vaccine, 12(16), pp. 1534-1536. (doi: 10.1016/0264-410X(94)90079-5) (PMID:7879420)

Taylor-Robinson, A. W., Liew, F. Y., Severn, A., Xu, D., McSorley, S. J., Garside, P. , Padron, J. and Phillips, R. S. (1994) Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. European Journal of Immunology, 24(4), pp. 980-984. (doi: 10.1002/eji.1830240430) (PMID:8149966)

Sands, W. A., Bulut, V., Severn, A., Xu, D. and Liew, F. Y. (1994) Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. European Journal of Immunology, 24(10), pp. 2345-2350. (doi: 10.1002/eji.1830241013) (PMID:7523136)

Severn, A., Xu, D., Doyle, J., Leal, L. M. C., O'Donnell, C. A. , Brett, S. J., Moss, D. W. and Liew, F. Y. (1993) Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity. European Journal of Immunology, 23(7), pp. 1711-1714. (doi: 10.1002/eji.1830230747) (PMID:7686861)

Cunha, F. Q., Assreuy, J., Xu, D., Charles, I., Liew, F. Y. and Moncada, S. (1993) Repeated induction of nitric oxide synthase and leishmanicidal activity in murine macrophages. European Journal of Immunology, 23(6), pp. 1385-1388. (doi: 10.1002/eji.1830230631) (PMID:7684689)

Book Sections

Ianaro, A., O'Donnell, C.A. and Xu, D. (1994) The role of nitric oxide in Carrageenin-induced inflammation. In: Moncada, S. (ed.) Biology of Nitric Oxide. Portland Press: London.

Conference Proceedings

Murphy, G.E.J., Pitman, N.I., Kurowska-Stolarska, M. , Kewin, P., Xu, D., McSharry, C., Thomson, N.C. and Shepherd, M.C. (2009) Murine airway eosinophilia following IL-33 administration is eotaxin dependent. In: American Thoracic Society 2009 International Conference, San Diego, CA, USA, 15-20 May 2009, A4253. (doi: 10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A4253)

Kurowska-Stolarska, M. S. , Kewin, P., Stolarski, B., Fraser, A., Xu, D., McInnes, I. and Liew, F. Y. (2008) A role of IL-33 in bone turnover. In: 72nd Annual Scientific Meeting of the American College of Rheumatology and the 43rd Annual Scientific Meeting of the Association of Rheumatology Health Professionals, San Francisco CA, USA, 24-29 Oct 2008, S895.

Kewin, P., Kurowska-Stolarska, M. , Murphy, G., Pitman, N., ChooKang, B., Patel, M., Xu, D., Liew, F.Y. and Thomson, N. (2008) IL-33 is sufficient to induce eosinophilic airway inflammation, and exacerbates established inflammation, through increased local Th2 cytokine and chemokine production. In: Scottish Thoracic Society Meeting, Stirling, UK, 26 Oct 2007, p. 50. (doi: 10.1258/rsmsmj.53.2.48)

Kewin, P., Kurowska-Stolarska, M. , Murphy, G., Pitman, N., ChooKang, B., Patel, M., Xu, D., Liew, F.Y. and Thomson, N. (2007) IL-33 is sufficient to induce eosinophilic airway inflammation, and exacerbates established inflammation, through increased ST2 dependent local Th2 cytokine and chemokine production. In: Winter Meeting of the British-Thoracic-Society, London, UK, 05-07 Dec 2007, A1.

This list was generated on Thu Dec 9 09:20:11 2021 GMT.